Guí a OncoSur de me l anoma 70 > BIBLIOGRAFÍA 1. Amin MB, Edge S, Greene F, et al. AJCC Cancer Staging Manual. 8th ed. New York, NY: Springer International Publishing; 2017. p. 1024. 2. Pawlik TM, Ross MI, Johnson MM, et al. Predictors and natural history of in-transit melanoma after sentinel lymphadenectomy. Ann Surg Oncol 2005:587-96. 3. Pflugfelder A, Kochs C, Blum A, et al. S3-Guideline “Diagnosis, therapy and follow-up of melanoma” - short version. JDDG 2013;563-603. 4. NCCN Clinical Practice Guidelines in Oncology: Melanoma. V4.2020. Disponible en: www.NCCN.org 5. Read RL, Stalley P, Thompson JF. The Contemporary Role of Major Amputation in the Management of Advanced Limb Melanoma. Ann Surg Oncol 2015:4067-72. 6. Read R, Haydu L, Saw RPM, et al. In-transit Melanoma Metastases: Incidence, Prognosis, and the Role of Lymphadenectomy. Ann Surg Oncol 2015:475-81. 7. Kunte C, Letule V, Gehl J, et al. Electrochemotherapy in the treatment of metastatic malignant melanoma: A prospective cohort study by InspECT. Br J Dermatol 2017;176(6):1475-85. 8. Moreno-Ramírez D, de la Cruz L, Ferrándiz L. Isolated Limb Perfusion for Malignant Melanoma: Systematic Review on Effectiveness and Safety. The Oncologist 2010;15:416-27. 9. Testori A, Ribero S, Bataille V. Diagnosis and treatment of in-transit melanoma metastases. Eur J Surg Oncol 2017;544-60. 10. Sigüenza M, Pizarro A, Mayor M, et al. Tratamiento tópico de las metástasis cutáneas de melanoma con imiquimod. Actas Dermosifiliogr 2005;96:111-5. 11. Nagore E, Sanmartín O, Botella-Estrada R, et al. Imiquimod para el tratamiento de las metástasis cutáneas de melanoma. Actas Dermosifiliogr 2005;96:549-50. 12. Green DS, Bodman-Smith MD, Dalgleish AG, et al. Phase I/II study of topical imiquimod and intralesiona interleukin-2 in the treatment of accesible metastases in malignant melanoma. Br J Dermatol 2007;156:337-45. 13. Radny P, Carola UM, Bauer J, et al. Phase II trial of intralesional therapy with interleukin-2 in soft-tissue melanoma metastases. P Radny y cols. Br J Cancer 2003;89:1620-6.
RkJQdWJsaXNoZXIy OTI4NTYw